Today on Meaghan’s Minute, brought to you by Memory Protection Devices, Stanford researchers have developed a nanotech microchip to help diagnose type-1 diabetes.
The microchip relies on a fluorescence-based method for detecting the antibodies. The team’s innovation is that the glass plates forming the base of each microchip are coated with an array of nanoparticle-sized islands of gold, which intensify the fluorescent signal, enabling reliable antibody detection allowing doctors to quickly and cheaply track their patients’ auto-antibody levels before they show symptoms.
For more informaiton visit www.memoryprotectiondevices.com and www.stanford.edu.
Are you interested in having your application featured in Meaghan’s Minute? Contact [email protected] for more information.
Filed Under: M2M (machine to machine)